These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5245432)

  • 1. Staphylococcus vaccines.
    Greenberg L
    Bull N Y Acad Med; 1968 Oct; 44(10):1222-6. PubMed ID: 5245432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunogenicity and antigenic properties of staphylococcal toxoid and vaccine in laboratory animals. II. Staphylococcal vaccine].
    Wysokińska T; Albrycht H
    Med Dosw Mikrobiol; 1973; 25(3):205-11. PubMed ID: 4760223
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunogenecity and antigenic properties of staphylococcal toxoid and vaccine in laboratory animals. I. Staphylococcal toxoid].
    Wysokìnska T; Albrycht H
    Med Dosw Mikrobiol; 1973; 25(3):193-204. PubMed ID: 4760222
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunogenic value of some staphylococcal antigens.
    Wysokińska T
    Contrib Microbiol Immunol; 1973; 1():281-2. PubMed ID: 4805309
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preparation of delayed-action staphylococcal vaccine. I. Effect of the vaccine on local skin infection in rabbits].
    Giedrys-Galant S; Hałasa J; Podkowińska I
    Med Dosw Mikrobiol; 1984; 36(2):77-85. PubMed ID: 6492938
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of serological tests as criteria for immunity to staphylococcal skin infection in rabbits.
    Cameron CM
    Onderstepoort J Vet Res; 1971 Jun; 38(2):99-101. PubMed ID: 5162614
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of protection against staphylococcal infection by vaccines.
    Kenney M; Illes CH
    N Y State J Med; 1966 May; 66(9):1084-7. PubMed ID: 5218380
    [No Abstract]   [Full Text] [Related]  

  • 8. A vaccine to prevent infections with Staphylococcus aureus.
    Thiemermann C
    Med Sci Monit; 2002 Sep; 8(9):LE35-6. PubMed ID: 12365409
    [No Abstract]   [Full Text] [Related]  

  • 9. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide.
    Maira-Litran T; Kropec A; Goldmann D; Pier GB
    Vaccine; 2004 Feb; 22(7):872-9. PubMed ID: 15040940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of staphylococcal infection with special reference to the preventive effect on "infection death" on mice pretreated with live or chrome-killed vaccine of various staphylococcal strains].
    Abe M
    Nihon Saikingaku Zasshi; 1966 Mar; (3):125-32. PubMed ID: 6005851
    [No Abstract]   [Full Text] [Related]  

  • 11. Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
    Projan SJ; Nesin M; Dunman PM
    Curr Opin Pharmacol; 2006 Oct; 6(5):473-9. PubMed ID: 16870507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus antigens and challenges in vaccine development.
    Middleton JR
    Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for active and passive immunization against Staphylococcus aureus.
    Shinefield HR; Black S
    Pediatr Infect Dis J; 2006 Feb; 25(2):167-8. PubMed ID: 16462297
    [No Abstract]   [Full Text] [Related]  

  • 14. [Various aspects of the specific immunological effect of staphylococcal vaccine favoring the use of autologous vaccines. I. Evaluation of phagocytosis and intracellular destruction of Staphylococci by rabbit granulocytes].
    Giedrys-Galant S
    Med Dosw Mikrobiol; 1987; 39(2):65-82. PubMed ID: 3657331
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental test of an ointment for surface staphylococcal infections].
    Parodi E; Acanfora D
    G Ig Med Prev; 1968; 9(2):179-85. PubMed ID: 5744724
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preparation of delayed-action staphylococcal vaccine. II. Effect of the vaccine on the course of generalized infection in mice].
    Giedrys-Galant S; Hałasa J; Podkowińska I
    Med Dosw Mikrobiol; 1984; 36(2):87-91. PubMed ID: 6492939
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of staphylococcal diseases].
    Ruiloba Benítez J
    Gac Med Mex; 1965 Dec; 95(12):1115-47. PubMed ID: 5889432
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the subcutaneous abscess formation and immunity in staphylococcal infection of mice.
    Tadokoro I
    Jpn J Exp Med; 1966 Feb; 36(1):6passim. PubMed ID: 5297258
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protective somatic antigen of staphylococci].
    Tolovskaia KR; Akatov AK
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Dec; 47(12):62-5. PubMed ID: 5511390
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental study on the prevention of the cavity formation. (The prevention of cavity formation by staphylococci)].
    Yamagata H; Ogawa Y; Nishi K; Abo J
    Arerugi; 1966 Jan; 15(1):37-47. PubMed ID: 5959746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.